|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.900 USD | +1.06% |
|
-6.86% | +38.69% |
| Market Cap | 649M 561M 517M 484M 908M 61.71B 921M 6.12B 2.38B 30.02B 2.44B 2.38B 104B | P/E Ratio 2026 * |
-2.63x | P/E Ratio 2027 * | -2.34x |
|---|---|---|---|---|---|
| Enterprise Value | 463M 400M 369M 346M 648M 44.05B 658M 4.37B 1.7B 21.43B 1.74B 1.7B 74.2B | EV / Sales 2026 * |
31,835x | EV / Sales 2027 * | 46.9x |
| Free-Float |
83.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | +1.06% | ||
| 1 week | -6.86% | ||
| Current month | -12.44% | ||
| 1 month | -16.67% | ||
| 3 months | -27.76% | ||
| 6 months | +22.58% | ||
| Current year | +38.69% |
| 1 week | 1.75 |  | 1.94 |
| 1 month | 1.75 | | 2.35 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 6.05 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Chang
CEO | Chief Executive Officer | 66 | 2018-05-31 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 2023-10-15 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 2017-10-31 |
David Chang
BRD | Director/Board Member | 66 | 2018-05-31 |
Joshua Kazam
BRD | Director/Board Member | 49 | 2017-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-20 | Sell | Controller/Auditor | 9,586 | 0.0039% | ||
| 03-30 | Sell | Chief Technology Officer | 2,867 | 0.0013% | ||
| 03-15 | Sell | Founder | 47,763 | 0.0213% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | -6.86% | +31.03% | -66.31% | 649M | |
| +1.03% | +7.52% | +54.74% | +114.98% | 55.58B | |
| +2.72% | +3.06% | +53.28% | +47.85% | 43.47B | |
| +1.12% | +1.06% | -14.15% | -17.13% | 22.64B | |
| +1.17% | -6.74% | -0.13% | +394.19% | 20.96B | |
| +3.81% | -4.13% | +16.62% | -30.70% | 15.79B | |
| +0.15% | +2.24% | +9.06% | -39.50% | 15.3B | |
| -0.69% | +1.22% | +28.24% | +176.72% | 13.45B | |
| +5.27% | +6.41% | +21.05% | - | 11.74B | |
| +1.61% | +1.17% | +90.79% | +212.97% | 10.96B | |
| Average | +1.61% | -0.55% | +29.05% | +88.12% | 21.05B | |
| Weighted average by Cap. | +1.58% | +1.57% | +33.62% | +100.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.55K 12.58K 11.59K 10.85K 20.35K 1.38M 20.66K 137K 53.34K 673K 54.6K 53.44K 2.33M | 11.69M 10.1M 9.31M 8.72M 16.34M 1.11B 16.59M 110M 42.84M 541M 43.85M 42.92M 1.87B |
| Net income | -195M -169M -155M -145M -273M -18.54B -277M -1.84B -715M -9.02B -731M -716M -31.22B | -234M -202M -186M -175M -327M -22.26B -332M -2.21B -858M -10.83B -878M -860M -37.49B |
| Net Debt | -186M -161M -148M -139M -260M -17.66B -264M -1.75B -681M -8.59B -697M -682M -29.74B | -101M -87.14M -80.27M -75.19M -141M -9.59B -143M -951M -370M -4.66B -378M -370M -16.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 1.900 $ | +1.06% | 8,636,227 |
| 26-06-11 | 1.880 $ | +5.62% | 6,102,343 |
| 26-06-10 | 1.780 $ | -2.20% | 7,943,853 |
| 26-06-09 | 1.820 $ | -1.62% | 7,723,891 |
| 26-06-08 | 1.850 $ | -1.60% | 9,264,181 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
